These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37865289)

  • 1. A qualitative assessment of tablet injectable opioid agonist therapy (TiOAT) in rural and smaller urban British Columbia, Canada: Motivations and initial impacts.
    Bowles J; Mansoor M; Werb D; Kerr T; Bardwell G
    J Subst Use Addict Treat; 2024 Feb; 157():209185. PubMed ID: 37865289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Access to tablet injectable opioid agonist therapy in rural and smaller urban settings in British Columbia, Canada: a qualitative study.
    Bardwell G; Bowles JM; Mansoor M; Werb D; Kerr T
    Subst Abuse Treat Prev Policy; 2023 Mar; 18(1):14. PubMed ID: 36869358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supervised Tablet Injectable Opioid Agonist Therapy (TiOAT): A Strategy to Address Safer Supply for Individuals With an Opioid Use Disorder?
    Weng J; Fairbairn N; Sutherland C; Johnson C; Nolan S
    J Addict Med; 2022 May-Jun 01; 16(3):258-260. PubMed ID: 34145188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feeling safer: effectiveness, feasibility, and acceptability of continuous pulse oximetry for people who smoke opioids at overdose prevention services in British Columbia, Canada.
    Moe J; Chavez T; Marr C; Cameron F; Feldman-Kiss D; Wang YE; Xavier JC; Mamdani Z; Purssell RA; Salmon A; Buxton JA
    Harm Reduct J; 2024 Feb; 21(1):45. PubMed ID: 38378610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of Safe Supply Alternatives During Intersecting COVID-19 and Overdose Health Emergencies in British Columbia, Canada, 2021.
    McNeil R; Fleming T; Mayer S; Barker A; Mansoor M; Betsos A; Austin T; Parusel S; Ivsins A; Boyd J
    Am J Public Health; 2022 Apr; 112(S2):S151-S158. PubMed ID: 35262376
    [No Abstract]   [Full Text] [Related]  

  • 6. A qualitative evaluation of a fentanyl patch safer supply program in Vancouver, Canada.
    Norton A; Ivsins A; Holliday E; Sutherland C; Kerr T; Kennedy MC
    Int J Drug Policy; 2024 Sep; 131():104547. PubMed ID: 39159532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns and history of prescription drug use among opioid-related drug overdose cases in British Columbia, Canada, 2015-2016.
    Smolina K; Crabtree A; Chong M; Zhao B; Park M; Mill C; Schütz CG
    Drug Alcohol Depend; 2019 Jan; 194():151-158. PubMed ID: 30439611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing prescribed hydromorphone: Alternative uses of safer supply and tablet-injectable opioid agonist treatment to meet unaddressed health needs.
    Ivsins A; Bowles JM; Mansoor M; Kerr T; Bardwell G
    Int J Drug Policy; 2024 Nov; 133():104601. PubMed ID: 39378778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.
    Irvine MA; Buxton JA; Otterstatter M; Balshaw R; Gustafson R; Tyndall M; Kendall P; Kerr T; Gilbert M; Coombs D
    Lancet Public Health; 2018 May; 3(5):e218-e225. PubMed ID: 29678561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying behaviours for survival and wellness among people who use methamphetamine with opioids in British Columbia: a qualitative study.
    Corser J; Palis H; Fleury M; Lamb J; Lock K; McDougall J; Mehta A; Newman C; Spence H; Buxton JA
    Harm Reduct J; 2022 May; 19(1):46. PubMed ID: 35590375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discontinuation and tapering of prescribed opioids and risk of overdose among people on long-term opioid therapy for pain with and without opioid use disorder in British Columbia, Canada: A retrospective cohort study.
    Kennedy MC; Crabtree A; Nolan S; Mok WY; Cui Z; Chong M; Slaunwhite A; Ti L
    PLoS Med; 2022 Dec; 19(12):e1004123. PubMed ID: 36454732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Convenience and comfort: reasons reported for using drugs alone among clients of harm reduction sites in British Columbia, Canada.
    Papamihali K; Yoon M; Graham B; Karamouzian M; Slaunwhite AK; Tsang V; Young S; Buxton JA
    Harm Reduct J; 2020 Nov; 17(1):90. PubMed ID: 33228676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk mitigation guidance and safer supply prescribing among young people who use drugs in the context of COVID-19 and overdose emergencies.
    Giang K; Charlesworth R; Thulien M; Mulholland A; Barker B; Brar R; Pauly B; Fast D
    Int J Drug Policy; 2023 May; 115():104023. PubMed ID: 37059025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of overdose and non-overdose mortality among people living with HIV amidst the illicit drug toxicity crisis in British Columbia.
    Yazdani K; Dhillon N; Tung A; Ye M; Trigg J; Stanley C; Ni Gusti Ayu N; McLinden T; Lima VD; Barrios R; Hogg R; Montaner JSG; Salters K
    AIDS Care; 2024 Feb; 36(2):263-271. PubMed ID: 37094365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motivations to initiate injectable hydromorphone and diacetylmorphine treatment: A qualitative study of patient experiences in Vancouver, Canada.
    Mayer S; Fowler A; Brohman I; Fairbairn N; Boyd J; Kerr T; McNeil R
    Int J Drug Policy; 2020 Nov; 85():102930. PubMed ID: 32949832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "It's just a perfect storm": Exploring the consequences of the COVID-19 pandemic on overdose risk in British Columbia from the perspectives of people who use substances.
    Foreman-Mackey A; Xavier J; Corser J; Fleury M; Lock K; Mehta A; Lamb J; McDougall J; Newman C; Buxton JA
    BMC Public Health; 2023 Apr; 23(1):640. PubMed ID: 37013524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescription-related risk factors for opioid-related overdoses in the era of fentanyl contamination of illicit drug supply: A retrospective case-control study.
    Smolina K; Crabtree A; Chong M; Park M; Mill C; Zhao B; Schütz CG
    Subst Abus; 2022; 43(1):92-98. PubMed ID: 32441588
    [No Abstract]   [Full Text] [Related]  

  • 18. "As long as that place stays open, I'll stay alive": Accessing injectable opioid agonist treatment during dual public health crises.
    Jaffe K; Blawatt S; Lehal E; Lock K; Easterbrook A; MacDonald S; Harrison S; Lajeunesse J; Byres D; Schechter M; Oviedo-Joekes E
    Harm Reduct J; 2023 Apr; 20(1):51. PubMed ID: 37060027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "It's Helped Me a Lot, Just Like to Stay Alive": a Qualitative Analysis of Outcomes of a Novel Hydromorphone Tablet Distribution Program in Vancouver, Canada.
    Ivsins A; Boyd J; Mayer S; Collins A; Sutherland C; Kerr T; McNeil R
    J Urban Health; 2021 Feb; 98(1):59-69. PubMed ID: 33118145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlates of concurrent use of stimulants and opioids among people who access harm reduction services in British Columbia, Canada: Findings from the 2019 Harm Reduction Client Survey.
    Lukac CD; Steinberg A; Papamihali K; Mehta A; Lock K; Buxton JA
    Int J Drug Policy; 2022 Apr; 102():103602. PubMed ID: 35124412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.